Newsletter and regulatory alerts
We write when a rule, a vote, or the evidence changes, not on a fixed schedule. Every item links to its primary source.
Subscribe
Regulatory alerts and the newsletter are one list, so one signup covers both.
Email only. Regulatory alerts and new evidence, sent when something changes. Unsubscribe any time.
What you get
Regulatory alerts
FDA 503A bulk list decisions, Pharmacy Compounding Advisory Committee votes, Federal Register notices, and WADA prohibited list changes, each linked to the primary document.
Evidence updates
When a new human trial changes an evidence grade, we say which grade moved and cite the study.
State access changes
Telehealth and compounding rule changes that affect how residents of a state can legally get a prescription.
What we do with your email
We ask for an email address and nothing else. It is used to send this list and is never sold or shared with advertisers or affiliate partners. Every email has a one-click unsubscribe link.
Prefer a feed? The regulatory tracker publishes the same events as an RSS feed.